Display options
Cite
Trejo CL, Luna G, Dravis C, et al. Lgr5 is a marker for fetal mammary stem cells, but is not essential for stem cell activity or tumorigenesis. NPJ Breast Cancer. 2017;3:16doi: 10.1038/s41523-017-0018-6.
Trejo, C. L., Luna, G., Dravis, C., Spike, B. T., & Wahl, G. M. (2017). Lgr5 is a marker for fetal mammary stem cells, but is not essential for stem cell activity or tumorigenesis. NPJ breast cancer, 316. https://doi.org/10.1038/s41523-017-0018-6
Trejo, Christy L, et al. "Lgr5 is a marker for fetal mammary stem cells, but is not essential for stem cell activity or tumorigenesis." NPJ breast cancer vol. 3 (2017): 16. doi: https://doi.org/10.1038/s41523-017-0018-6
Trejo CL, Luna G, Dravis C, Spike BT, Wahl GM. Lgr5 is a marker for fetal mammary stem cells, but is not essential for stem cell activity or tumorigenesis. NPJ Breast Cancer. 2017 Apr 24;3:16. doi: 10.1038/s41523-017-0018-6. eCollection 2017. PMID: 28649656; PMCID: PMC5460261.
Copy Download .nbib Format: NLM
Share it on

NPJ Breast Cancer. 2017 Apr 24;3:16. doi: 10.1038/s41523-017-0018-6. eCollection 2017.

Lgr5 is a marker for fetal mammary stem cells, but is not essential for stem cell activity or tumorigenesis.

NPJ breast cancer

Christy L Trejo, Gidsela Luna, Christopher Dravis, Benjamin T Spike, Geoffrey M Wahl

Affiliations

  1. Salk Institute for Biological Studies, Gene Expression Laboratory, La Jolla, CA 92037 USA.
  2. Huntsman Cancer Institute, University of Utah, Salt Lake City, 84103 UT USA.

PMID: 28649656 PMCID: PMC5460261 DOI: 10.1038/s41523-017-0018-6

Abstract

The search for the bipotent mammary stem cells that drive mammary development requires markers to enable their prospective isolation. There is general agreement that bipotent mouse mammary stem cells are abundant in late fetal development, but their existence in the adult is vigorously debated. Among markers useful for mammary stem cell identification, the Wnt co-receptor Lgr5 has been suggested by some to be both "necessary and sufficient" for bipotency and transplantation of adult mammary stem cell activity, though other studies disagree. Importantly, the relevance of Lgr5 to the bipotency of fetal mammary stem cells has not been studied. We show here that expression of a fluorescent protein driven by the endogenous Lgr5 promoter enables significant fetal mammary stem cell enrichment. We used lineage tracing to demonstrate embryonic cells expressing Lgr5 are bipotent, while their adult counterparts are myoepithelial restricted. Importantly, our data conclusively demonstrate that Lgr5 is dispensable for both fetal and adult mammary stem cell activity and for the development of mammary tumors.

References

  1. J Pathol. 2012 Nov;228(3):300-9 - PubMed
  2. Cell. 1982 Nov;31(1):99-109 - PubMed
  3. World J Surg Oncol. 2012 Nov 15;10 :244 - PubMed
  4. Nat Cell Biol. 2014 Oct;16(10):942-50, 1-7 - PubMed
  5. Breast Cancer Res. 2014 Dec 03;16(6):487 - PubMed
  6. Cell Rep. 2015 Sep 29;12(12):2035-48 - PubMed
  7. Development. 2004 Oct;131(19):4819-29 - PubMed
  8. Carcinogenesis. 2013 May;34(5):1150-7 - PubMed
  9. Nature. 2007 Oct 25;449(7165):1003-7 - PubMed
  10. Cell Stem Cell. 2010 Jun 4;6(6):568-77 - PubMed
  11. Dev Biol. 2014 Jun 15;390(2):181-90 - PubMed
  12. Nat Neurosci. 2010 Jan;13(1):133-40 - PubMed
  13. Nature. 2011 Oct 09;479(7372):189-93 - PubMed
  14. Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6991-6 - PubMed
  15. Stem Cells. 2015 Oct;33(10):2913-24 - PubMed
  16. Cell Rep. 2013 Jan 31;3(1):70-8 - PubMed
  17. Stem Cells. 2013 Sep;31(9):1921-31 - PubMed
  18. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):740-4 - PubMed
  19. Nature. 2015 Jan 1;517(7532):81-4 - PubMed
  20. Genes Dev. 2016 Jun 1;30(11):1261-77 - PubMed
  21. Stem Cell Reports. 2014 Apr 03;2(4):427-39 - PubMed
  22. Methods Mol Biol. 2010;621:29-47 - PubMed
  23. J Mammary Gland Biol Neoplasia. 2013 Jun;18(2):209-19 - PubMed
  24. Cell Stem Cell. 2012 Feb 3;10(2):183-97 - PubMed
  25. Nature. 2014 Feb 20;506(7488):322-7 - PubMed
  26. Nat Cell Biol. 2016 Dec;18(12 ):1346-1356 - PubMed
  27. J Immunol Methods. 2009 Aug 15;347(1-2):70-8 - PubMed
  28. Nature. 2005 Apr 14;434(7035):843-50 - PubMed
  29. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11236-40 - PubMed
  30. Development. 2013 Jun;140(12):2484-94 - PubMed
  31. Cell Stem Cell. 2012 Sep 7;11(3):387-400 - PubMed
  32. Nature. 2006 Feb 23;439(7079):993-7 - PubMed
  33. Genome Biol. 2013 Nov 12;14(11):R125 - PubMed
  34. Mol Cell Biol. 2004 Nov;24(22):9736-43 - PubMed
  35. Sex Dev. 2011;5(4):205-12 - PubMed

Publication Types

Grant support